Longevity Health Holdings Inc (XAGE) - Market Cap to Earnings

Longevity Health Holdings (XAGE) is driving innovation in regenerative cosmetology by creating tissue restoration biomaterials backed by a robust patent portfolio. The business is scaling the distribution of plasma gels through third-party capacities to avoid plant expenditures. Growth is driven by the market launch of Carmell products and demand for premium care. Serving as the primary valuation tool, this chart of quotes on GURU.Markets confirms independence from macro cycles at a value of -0.60.

Carmell Corp - XAGE Price to Earnings Ratio (period 04/04/2025 - 09/20/2025)

Analytical breakdowns for Longevity Health Holdings

- stock value and consensus price forecast:

Stock Quotes Carmell Therapeutics|XAGE - Analyst Consensus Forecast

- market capitalization indicators:

Market Value Longevity Health Holdings Inc|XAGE - Total Company Value

- book value of equity indicators:

Equity per Share Longevity Health Holdings|XAGE - Company Net Assets|Market Cap to Book Value Multiple carmellcosmetics.com|XAGE - Aggregate Company Assets

- company liabilities and liquidity data:

- financial results and valuation multiples details:

XAGE - Net Income|Expected Profit Longevity Health Holdings|XAGE - P/E Multiple|Market Cap to Projected Earnings Longevity Health Holdings|XAGE - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio Carmell Corp|XAGE - Operating profit before deduction of amortization|Net earnings per one share for the last twelve months Longevity Health Holdings|XAGE - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months carmellcosmetics.com|XAGE - Earnings growth in current year|Expected earnings per share trend next year Longevity Health Holdings

- issuer revenue and sales details:

XAGE - Revenue and Sales Volume|Company Expected Sales Volume Carmell Therapeutics|XAGE - P/S Multiple|Forward P/S Multiple Longevity Health Holdings Inc|XAGE - Sales Growth YoY (Last Twelve Months)

Comprehensive company analysis:Carmell Therapeutics XAGE

Innovations in regenerative medicine and biochemistry create high added value for Longevity Health Holdings (XAGE) products. The price-to-earnings ratio dynamics reflect the market valuation of these technological advantages. This metric measures the business value relative to its net income, accounting for daily exchange rate fluctuations. The upward curve confirms investor confidence, although it increases the risk of overpayment during trend reversals. The asset is categorized as a high-tech investment.

Key competitors